by Jake Ciszewski | Jan 6, 2024
Robin Kate Kelley, professor of clinical medicine in the division of hematology/oncology, University of California, San Francisco, dissects biliary tract cancer. Transcription: My name is Katie Kelley, and I’m a GI Medical Oncologist at the University of...
by Jake Ciszewski | Jan 5, 2024
Kim Moran, SVP, head of U.S. Rare Diseases, discusses new treatments being approved by the FDA to combat myasthenia gravis. Transcription Hi, I’m Kim Moran. I am the Head of U.S. Rare Disease for the US, for UCB. I get to help people living with rare diseases...
by Jake Ciszewski | Jan 4, 2024
Björn Mellgård, MD, PhD, Vice President, Global Program Lead, Rare Genetics and Hematology, Takeda, discusses Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Transcription: My name is Björn Mellgård. As you may understand from that name, I’m from...
by Jake Ciszewski | Jan 3, 2024
Cat Lutz, PhD, Vice President of the Rare Disease Translational Center at The Jackson Laboratory, discusses how Jackson Laboratory uses mice in testing for human disease. My name is Cat Lutz. I’m the vice president of the Rare Disease Translational Center at The...
by Jake Ciszewski | Jan 20, 2023
Ryan Jacobs, MD, from the Atrium Health Levine Cancer Institute in Charlotte, North Carolina, discusses 4-year follow up data from the phase 2 CAPTIVATE study, which evaluated ibrutinib plus venetoclax as a first-line treatment for chronic lymphocytic leukemia...
